Barry Littlejohns, President, Biologics & SDD at Catalent, Inc. (CTLT), sold 192,076 shares at $41.64 ($8.0M) on 2018-10-15, disclosed to the SEC on 2018-10-17.
Open-market sale of $8.0M CTLT by President, Biologics & SDD. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.64 | 3,222 | $134K | 1.7% |
| 2 | $41.64 | 15,768 | $657K | 8.2% |
| 3 | $41.64 | 19,616 | $817K | 10.2% |
| 4 | $41.64 | 47,265 | $2.0M | 24.6% |
| 5 | $41.64 | 47,265 | $2.0M | 24.6% |
| 6 | $41.64 | 58,940 |
| $2.5M |
| 30.7% |
| Total | $41.64 avg | 192,076 | $8.0M | 100% |